1. Home
  2. RVMD vs MNSO Comparison

RVMD vs MNSO Comparison

Compare RVMD & MNSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • MNSO
  • Stock Information
  • Founded
  • RVMD 2014
  • MNSO 2013
  • Country
  • RVMD United States
  • MNSO China
  • Employees
  • RVMD N/A
  • MNSO N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • MNSO Department/Specialty Retail Stores
  • Sector
  • RVMD Health Care
  • MNSO Consumer Discretionary
  • Exchange
  • RVMD Nasdaq
  • MNSO Nasdaq
  • Market Cap
  • RVMD 8.7B
  • MNSO 7.2B
  • IPO Year
  • RVMD 2020
  • MNSO 2020
  • Fundamental
  • Price
  • RVMD $41.33
  • MNSO $19.99
  • Analyst Decision
  • RVMD Strong Buy
  • MNSO Hold
  • Analyst Count
  • RVMD 13
  • MNSO 4
  • Target Price
  • RVMD $65.15
  • MNSO $20.90
  • AVG Volume (30 Days)
  • RVMD 1.2M
  • MNSO 839.2K
  • Earning Date
  • RVMD 02-26-2025
  • MNSO 03-11-2025
  • Dividend Yield
  • RVMD N/A
  • MNSO 2.82%
  • EPS Growth
  • RVMD N/A
  • MNSO 2.83
  • EPS
  • RVMD N/A
  • MNSO 1.23
  • Revenue
  • RVMD $742,000.00
  • MNSO $2,501,784,871.00
  • Revenue This Year
  • RVMD N/A
  • MNSO $14.96
  • Revenue Next Year
  • RVMD $1,855.56
  • MNSO $22.06
  • P/E Ratio
  • RVMD N/A
  • MNSO $18.43
  • Revenue Growth
  • RVMD N/A
  • MNSO 9.45
  • 52 Week Low
  • RVMD $28.95
  • MNSO $12.51
  • 52 Week High
  • RVMD $62.40
  • MNSO $27.71
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 44.66
  • MNSO 35.28
  • Support Level
  • RVMD $40.13
  • MNSO $21.85
  • Resistance Level
  • RVMD $42.68
  • MNSO $23.20
  • Average True Range (ATR)
  • RVMD 1.41
  • MNSO 0.80
  • MACD
  • RVMD 0.10
  • MNSO -0.20
  • Stochastic Oscillator
  • RVMD 26.42
  • MNSO 6.74

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

About MNSO MINISO Group Holding Limited

MINISO Group Holding Ltd is a retailer offering a variety of design-led lifestyle products. The principal activity of the Company is investment holding. The company's product categories include home decor, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care, snacks, fragrance and perfumes, and stationery and gifts. Its segment includes the MINISO brand, which is engaged in the Design, buying and sale of lifestyle products, and the TOP TOY brand, which is engaged in the Design, buying and sale of pop toys. The company generates maximum revenue from the MINISO brand segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: